NASDAQ: YDES
Yd Biopharma Ltd Stock Ownership - Who owns Yd Biopharma?

Insider buying vs selling

Have Yd Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when YDES insiders and whales buy or sell their stock.

YDES Shareholders

What type of owners hold Yd Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
J. Douglas Ramsey3.67%2,575,000$30.96MInsider
Geode Capital Management LLC0.08%53,071$638.18kInstitution
Cerity Partners LLC0.05%32,406$389.68kInstitution
Hrt Financial LP0.05%31,819$382.62kInstitution
Cypress Capital Management LLC Wy0.04%29,990$360.63kInstitution
Ubs Group Ag0.01%10,316$124.05kInstitution
Morgan Stanley0.01%10,257$123.34kInstitution
Clear Street Group Inc0.01%7,500$90.19kInstitution
Bnp Paribas Financial Markets0.00%90$1.08kInstitution
Barclays PLC0.00%58$697.45Institution

1 of 2

YDES vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
YDES0.25%3.67%
MPLT0.00%53.72%Net Buying
ARVN74.71%25.29%Net SellingNet Selling
DBVT3.85%19.90%Net SellingNet Selling
GERN79.43%1.09%Net BuyingNet Buying

Yd Biopharma Stock Ownership FAQ

Who owns Yd Biopharma?

Yd Biopharma (NASDAQ: YDES) is owned by 0.25% institutional shareholders, 3.67% Yd Biopharma insiders, and 96.08% retail investors. J. Douglas Ramsey is the largest individual Yd Biopharma shareholder, owning 2.58M shares representing 3.67% of the company. J. Douglas Ramsey's Yd Biopharma shares are currently valued at $31.31M.

If you're new to stock investing, here's how to buy Yd Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.